(CNN)The antibodies in Evusheld, the only therapy available to protect people with reduced immune function against Covid-19, may lose their punch against the BA.4.6 subvariant, a new study shows.
#people #information #united-states #effectively #essentially #combination #spokesperson #disease-control #astrazeneca #transmission
[
add
]
[
|
|
...
]